Climbers using xenon gas to climb Everest

Medical and Physiological Concerns

• Traditional 6–8 week acclimatization is framed as essential for red blood cell adaptation, vascular changes, and respiratory conditioning that cannot be safely rushed.
• Critics argue xenon-induced EPO boosts create “thicker blood” atop already increased altitude viscosity, raising risks of clots, stroke, and heart attack.
• Rapid ascent without acclimatization is linked to higher risk of AMS, HAPE, and HACE, especially above 8,000m.
• Individual responses to xenon/EPO are said to be unpredictable, making safe dosing at extreme altitude unclear.
• Some ask whether there is actual evidence of increased mortality from xenon use versus speculation; the thread does not provide hard data.

Performance Enhancement, Legality, and Alternatives

• Xenon is noted as banned by WADA; using it for running a marathon, for instance, would be considered doping.
• Compared with altitude tents and hypoxic training masks, xenon is seen as a more convenient but potentially riskier shortcut.
• Hypoxic tents are described as noisy, hot, uncomfortable, requiring 12+ hours/day; their benefits for non-elite athletes are questioned.
• Hypoxic masks for casual or detrained athletes are warned against as counterproductive.

Cost, Commercialization, and “Pay-to-Win”

• Xenon sessions are reported at ~$5,000 for 30 minutes, with full xenon-assisted Everest packages in the six-figure range.
• Several comments highlight xenon, high-end guiding, and fixed-rope “expedition style” as symbols of Everest becoming a rich-person, pay-to-win objective.
• Others reply that even guided, oxygen-assisted Everest remains extremely demanding and beyond what most people can do.

Ethics, Meaning, and Sherpa Risk

• Strong criticism of clients who use xenon, heavy Sherpa support, and minimal skills while claiming “I climbed Everest”; likened to being pulled through a marathon in a rickshaw.
• Concern that xenon-shortened climbs increase danger for both clients and Sherpas, with limited ability to retreat during acclimatization.
• Counterpoint: people knowingly accept risk; Sherpas and local economies depend on high-paying expeditions.

Skepticism About the “Trend”

• Some suspect the xenon-Everest idea is mostly marketing: a Financial Times feature and PDFs are hosted by the very company selling $5k xenon sessions.
• Unclear whether this is a real, growing practice or a publicity-driven one-off.

Xenon’s Other Effects

• Xenon is noted as a potent but expensive anesthetic and psychoactive gas, potentially acting via lipid solubility and possibly microtubule-related mechanisms, though details remain scientifically unsettled.